Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?
about
Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeuticsBone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patientsSEOM Clinical Guideline for bone metastases from solid tumours (2016).Characterization of a rat model of metastatic prostate cancer bone pain.The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer.
P2860
Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Biochemical approach to the de ...... d what questions need answers?
@ast
Biochemical approach to the de ...... d what questions need answers?
@en
type
label
Biochemical approach to the de ...... d what questions need answers?
@ast
Biochemical approach to the de ...... d what questions need answers?
@en
prefLabel
Biochemical approach to the de ...... d what questions need answers?
@ast
Biochemical approach to the de ...... d what questions need answers?
@en
P2093
P1476
Biochemical approach to the de ...... d what questions need answers?
@en
P2093
Claus Christiansen
Diana J Leeming
László B Tankó
Morten A Karsdal
P2888
P304
P356
10.1007/S10555-006-9024-0
P577
2006-12-01T00:00:00Z